Effect of triiodothyronine (T3) on myocardial high energy phosphates and lactate after ischemia and cardiopulmonary bypass. An experimental study in baboons
- PMID: 3172806
Effect of triiodothyronine (T3) on myocardial high energy phosphates and lactate after ischemia and cardiopulmonary bypass. An experimental study in baboons
Abstract
Cardiopulmonary bypass is associated with a reduction in plasma free triiodothyronine in patients undergoing cardiac operations. A previous experimental study in pigs demonstrated a marked inotropic effect when triiodothyronine was administered after a period of myocardial ischemia and cardiopulmonary bypass; this was associated with a significant reduction in mortality compared with the mortality in control pigs. To clarify the effect of triiodothyronine on myocardial high energy phosphate stores and lactate, a series of experiments was done in baboons undergoing 3 hours of myocardial ischemia while supported by cardiopulmonary bypass. Seven baboons received no triiodothyronine and six received 6 micrograms of triiodothyronine at the end of the ischemic period. Seventy minutes after cardiopulmonary bypass, the myocardial adenosine triphosphate level was significantly higher (p less than 0.01) in the treated animals. In untreated animals, a steady increase in myocardial lactate occurred after cardiopulmonary bypass; by 120 minutes after ischemia (70 minutes after cardiopulmonary bypass) there was a significant difference in lactate levels between the two groups (p less than 0.01). We postulate that a combination of global ischemia and depletion of triiodothyronine results in reduced mitochondrial function, inhibition of the tricarboxylic acid cycle, and increased anaerobic metabolism and depletion of myocardial phosphates. Triiodothyronine replacement therapy leads to improved mitochondrial function and increased aerobic metabolism, which results in increased synthesis of myocardial phosphates. We suggest that there may be a place for the administration of triiodothyronine in patients undergoing cardiac operations with a prolonged myocardial ischemic period or in whom there is any evidence of low cardiac output after discontinuation of cardiopulmonary bypass.
Comment in
-
Changes in triiodothyronine during cardiopulmonary bypass: a clinical problem?J Thorac Cardiovasc Surg. 1990 Sep;100(3):464-5. J Thorac Cardiovasc Surg. 1990. PMID: 2391986 No abstract available.
Similar articles
-
Changes in myocardial high-energy phosphate stores and carbohydrate metabolism during intermittent aortic crossclamping in dogs on cardiopulmonary bypass at 34 degrees and 25 degrees C.J Thorac Cardiovasc Surg. 1990 Sep;100(3):389-99. J Thorac Cardiovasc Surg. 1990. PMID: 2095756
-
Inadequate myocardial protection with cold cardioplegic arrest during repair of tetralogy of Fallot.J Thorac Cardiovasc Surg. 1988 Feb;95(2):223-9. J Thorac Cardiovasc Surg. 1988. PMID: 3257536
-
Intermittent aortic cross-clamping versus St. Thomas' Hospital cardioplegia in extensive aorta-coronary bypass grafting. A randomized clinical study.J Thorac Cardiovasc Surg. 1984 Aug;88(2):164-73. J Thorac Cardiovasc Surg. 1984. PMID: 6379305 Clinical Trial.
-
Thyroid hormone and the stunned myocardium.J Endocrinol. 2014 Oct;223(1):R1-8. doi: 10.1530/JOE-14-0389. Epub 2014 Aug 15. J Endocrinol. 2014. PMID: 25128568 Review.
-
Novel actions of thyroid hormone: the role of triiodothyronine in cardiac transplantation.Thyroid. 1996 Oct;6(5):531-6. doi: 10.1089/thy.1996.6.531. Thyroid. 1996. PMID: 8936684 Review.
Cited by
-
Changes of serum TSH, FT3, and FT4 levels in infants received surgical correction of congenital heart disease under cardiopulmonary bypass.BMC Cardiovasc Disord. 2023 Nov 16;23(1):562. doi: 10.1186/s12872-023-03590-4. BMC Cardiovasc Disord. 2023. PMID: 37974091 Free PMC article.
-
The euthyroid sick syndrome: is there a physiologic rationale for thyroid hormone treatment?J Endocrinol Invest. 2003 Dec;26(12):1174-9. doi: 10.1007/BF03349153. J Endocrinol Invest. 2003. PMID: 15055468 Review. No abstract available.
-
Activated FGF2 signaling pathway in tumor vasculature is essential for acquired resistance to anti-VEGF therapy.Sci Rep. 2020 Feb 19;10(1):2939. doi: 10.1038/s41598-020-59853-z. Sci Rep. 2020. PMID: 32076044 Free PMC article.
-
Overcoming Coagulation Dysregulation in Pig Solid Organ Transplantation in Nonhuman Primates: Recent Progress.Transplantation. 2018 Jul;102(7):1050-1058. doi: 10.1097/TP.0000000000002171. Transplantation. 2018. PMID: 29538262 Free PMC article. Review.
-
Progress in Orthotopic Pig Heart Transplantation in Nonhuman Primates.Transpl Int. 2024 Sep 27;37:13607. doi: 10.3389/ti.2024.13607. eCollection 2024. Transpl Int. 2024. PMID: 39399753 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources